COUVÉ, Eloïse; LAHOUATI, Marin; LEITAO, Julie; MEIRELES, Vasco Dias; DAUCHY, Frederic; XUEREB, Fabien

doi:10.1016/j.idnow.2025.105104

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

COUVÉ, Eloïse

LAHOUATI, Marin
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases

LEITAO, Julie

Idioma

Article de revue

Este ítem está publicado en

Infectious Diseases Now. 2025-05-28p. 105104

Resumen en inglés

Patients with bone and joint infections (BJI) are part of a complex care pathway. This study aimed to evaluate the economic impact of clinical pharmacist-led interventions in the management of BJI patients. We performed a retrospective study documenting all pharmacist-led interventions (PI). Their impact was assessed using the clinical economic and organizational scale (CLEO SFPC). The probability of adverse drug events (ADE) in the absence of PI was assessed by a panel of three experts. Cost avoidance was calculated for PIs with major clinical impact using a cost of €5,331 per event, multiplied by the probability of ADE occurrence. A total of 41 PIs had a major clinical impact. Cost avoidance associated with the intervention of a pharmacist was estimated at €83,750.01 during the study. The implementation of pharmacist-led interventions in the management of patients with BJI helps avoid preventable healthcare costs.< Leer menos

Palabras clave en inglés

Adverse events; Antibiotics; Bone and joint infection; Clinical pharmacy; Medication safety.

Metadatos

Compartir este ítem

Licencia de uso del documento

CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections.

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación